Antidepressive response to add-on occupational therapy in patients with major depression

Phase 4, randomised trial of mirtazapine in major depressive disorder (MDD) (2 arms), sponsored by LWL University Hospital Bochum. Primary endpoints: Change in Hamilton Depression Rating Scale from baseline to Day 42 and Weekly change in Hamilton Depression Rating Scale from baseline to Days 1–21. Started Jan 2010; status: active.